Modified CLIP using PIVKA-II for evaluating prognosis after hepatectomy for hepatocellular carcinoma

European Journal of Surgical Oncology

Volumn 29, Issue 9, 2003, Pages 735-742

  Nanashima, Alpha ^a   Morino, S ^a   Yamaguchi, H ^a   Tanaka, K ^a   Shibasaki, S ^a   Tsuji, T ^a   Hidaka, S ^a   Sawai, T ^a   Yasutake, T ^a   Nakagoe, T ^a  

^a NAGASAKI UNIVERSITY   (Japan)

Author keywords

CLIP; Hepatic resection; Hepatocellular carcinoma; PIVKA II; Prognosis

Indexed keywords

FLUOROURACIL; VITAMIN K GROUP;

ADULT; AGED; ARTICLE; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; HUMAN; LIVER CELL CARCINOMA; LIVER DYSFUNCTION; LIVER RESECTION; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; PROTEIN DETERMINATION; PROTEIN INDUCTION; SCORING SYSTEM;

EID: 0344464866     PISSN: 07487983     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejso.2003.08.007     Document Type: Article

References (25)

1. Makuuchi M, Takayama T, Kubota K, Kimura W, Midorikawa Y, Miyagawa S et al. Hepatic resection for hepatocellular carcinoma - Japanese experience. Hepatogastroenterology 1998; 45: 1267-74.
2. Yamamoto J, Okada S, Shimada K, Okusaka T, Yamasaki S, Ueno H et al. Treatment strategy for small hepatocellular carcinoma: comparison of long-term results after percutaneous ethanol injection therapy and surgical resection. Hepatology 2001; 34: 707-14.
3. Yamasaki S, Hasegawa H, Kinoshita H, Furukawa M, Imaoka S, Takasaki K et al. A prospective randomised trial of the preventive effect of pre-operative transcatheter arterial embolization against recurrence of hepatocellular carcinoma. Jpn J Cancer Res 1996; 87: 206-11.
4. Adachi E, Maehara S, Tsujita E, Taguchi K, Aishima S, Rikimaru T et al. Clinicopathologic risk factors for recurrence after a curative hepatic resection for hepatocellular carcinoma. Surgery 2002; 131(Suppl. 1): 148-52.
5. Adachi E, Maeda T, Matsumata T, Shirabe K, Kinukawa N, Sugimachi K et al. Risk factors for intrahepatic recurrence in human small hepatocellular carcinoma. Gastroenterology 1995; 108: 768-75.
6. Ko S, Nakajima Y, Kanehiro H, Hisanaga M, Aomatsu Y, Kin T et al. Significant influence of accompanying chronic hepatitis status on recurrence of hepatocellular carcinoma after hepatectomy. Result of multivariate analysis. Ann Surg 1996; 224: 591-5.
7. Anonymous - Liver Cancer Study Group of Japan, Predictive factors for long-term prognosis after partial hepatectomy for patients with hepatocellular carcinoma in Japan. Cancer 1994; 74: 2772-80.
8. Sobin LH, Wittekind CH. Liver (ICD-O C22), TNM Classification of Malignant Tumours, 6th edn. New York: Wiley, 2002. p. 81-3.
9. Pugh RNH, Murray-Lyon IM, Dawson JL, Pietroni MC, Williams R. Transection of the oesophagus for bleeding oesophageal varices. Br J Surg 1973; 60: 646-9.
10. Liver Cancer Study Group of Japan, The General Rules for the Clinical and Pathological Study of Primary Liver Cancer, 4th edn. Tokyo: Kanehara and Co., Ltd, 2000. p. 11-34.
11. Okuda K, Ohtsuki T, Obata H, Tomimatsu M, Okazaki N, Hasegawa H et al. Natural history of hepatocellular carcinoma and prognosis in relation to treatment. Study of 850 patients. Cancer 1985; 56: 918-28.
12. The Cancer of the Liver Italian Program (CLIP) investigators, A new prognostic system for hepatocellular carcinoma: a retrospective study of 435 patients. Hepatology 1998; 28: 751-5.
13. The Cancer of the Liver Italian Program (CLIP) investigators, Prospective validation of the CLIP score: a new prognostic system for patients with cirrhosis and hepatocellular carcinoma. Hepatology 2000; 31: 840-5.
14. The Liver Cancer Study Group of the University of Toronto, Levy I, Sherman M. Staging of hepatocellular carcinoma: assessment of the CLIP, Okuda, and Child-Pugh staging systems in a cohort of 257 patients in Toronto. Gut 2002; 50: 881-5.
15. Ueno S, Tanabe G, Sako K, Hiwaki T, Hokotate H, Fukukura Y et al. Discrimination value of the new western prognostic system (CLIP score) for hepatocellular carcinoma in 662 Japanese patients. Hepatology 2001; 34: 529-34.
16. Zhao WH, Ma ZM, Zhou XR, Feng YZ, Fang BS. Prediction of recurrence and prognosis in patients with hepatocellular carcinoma after resection by use of CLIP score. World J Gastroenterol 2002; 8: 237-42.
17. Nakagawa T, Seki T, Shiro T, Wakabayashi M, Imamura M, Itoh T et al. Clinicopathologic significance of protein induced vitamin K absence or antagonist II and alpha-fetoprotein in hepatocellular carcinoma. Int J Oncol 1999; 14: 281-6.
18. Okuda H, Nakanishi T, Takatsu K, Saito A, Hayashi N, Yamamoto M et al. Clinicopathologic features of patients with hepatocellular carcinoma seropositive for alpha-fetoprotein-L3 and seronegative for des-gamma-carboxy prothrombin in comparison with those seropositive for des-gamma-carboxy prothrombin alone. J Gastroenterol Hepatol 2002; 17: 772-8.
19. Chiappa A, Zbar AP, Podda M, Audisio RA, Bertani E, Biella F et al. Prognostic value of the modified TNM classification of hepatocellular carcinoma in 53 cirrhotic patients undergoing resection. Hepotogastroenterology 2001; 48: 229-34.
20. Izumi R, Shimizu K, Ii T, Yagi M, Matsui O, Nonomura A et al. Prognostic factors of hepatocellular carcinoma in patients undergoing hepatic resection. Gastroenterology 1994; 106: 720-7.
21. Befeler AS, Di Bisceglie AM. Hepatocellular carcinoma: diagnosis and treatment. Gastroenterology 2002; 122: 1609-19.
22. Suehiro T, Sugimachi K, Matsumata T, Itasaka H, Taketomi A, Maeda T. Protein induced by vitamin K absence or antagonist II as a prognostic marker in hepatocellular carcinoma. Comparison with alpha-fetoprotein. Cancer 1994; 73: 2464-71.
23. Hanazaki K, Kajikawa S, Koide N, Adachi W, Amano J. Prognostic factors after hepatic resection for hepatocellular carcinoma with hepatitis C viral infection: univariate and multivariate analysis. Am J Gastroenterol 2001; 96: 1243-50.
24. Nonami T, Harada A, Kurokawa T, Nakao A, Takagi H. Hepatic resection for hepatocellular carcinoma. Am J Surg 1997; 173: 288-91.
25. Llovet JM, Bru C, Bruix J. Prognosis of hepatocellular carcinoma: the BCLC staging classification. Semin Liver Dis 1999; 19: 329-38.